Results 161 to 170 of about 65,038 (202)
Some of the next articles are maybe not open access.
Allelotyping in B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Leukemia & Lymphoma, 2004B-cell chronic lymphocytic leukemia (B-CLL) is a heterogeneous malignant disease, both in terms of molecular abnormalities and clinical course. The most frequent chromosomal aberrations in B-CLL are deletions on 13q, 11q, and 17p, and trisomy 12, all of which are of prognostic significance.
Urban, Novak +2 more
openaire +2 more sources
Tumor Suppressor Genes and Clonal Evolution in B-CLL
Leukemia & Lymphoma, 1995This review highlights the genetic alterations that have been detailed in the malignant B-cell clones of patients with B-chronic lymphocytic leukemia (CLL). In particular, the alterations seen in p53 and the retinoblastoma (Rb) genes are reviewed. In addition, the multiplicity of cytogenetic alterations observed at baseline and on sequential analysis ...
N E, Kay, E A, Ranheim, L C, Peterson
openaire +2 more sources
A novel B-CLL specific nuclear protein (p44/46)
Leukemia Research, 1999Our previous results indicated some diversities in electrophoretic patterns of proteins from different cellular fractions, i.e. nuclear, mitochondrial, microsomal and cytosolic isolated from mononuclear cells from the peripheral blood of B cell chronic lymphocytic leukemia (B-CLL) patients and healthy donors.
J, Chruściel +4 more
openaire +2 more sources
[Rinsho ketsueki] The Japanese journal of clinical hematology, 1991
Most of human follicular lymphomas (approximately 90% in U.S.A. or approximately 30% in Japan) possess the t(14; 18) chromosome translocation that directly involves the IgH locus on chromosome 14 and the bcl-2 gene on chromosome 18. The t(14; 18) chromosome translocation occurs nearly exclusively at two hot spots, a major breakpoint clustering region ...
M, Adachi +3 more
openaire +1 more source
Most of human follicular lymphomas (approximately 90% in U.S.A. or approximately 30% in Japan) possess the t(14; 18) chromosome translocation that directly involves the IgH locus on chromosome 14 and the bcl-2 gene on chromosome 18. The t(14; 18) chromosome translocation occurs nearly exclusively at two hot spots, a major breakpoint clustering region ...
M, Adachi +3 more
openaire +1 more source
CD1 expression in B-CLL cells.
Nouvelle revue francaise d'hematologie, 1989The peripheral blood from 38 B-CLL patients was studied by flow cytometry with 25 clustered or not clustered monoclonal antibodies (moAbs) in order to characterize the cell surface phenotype of lymphoid cells. All moAbs were chosen since they detected B or CD1-8 T cell differentiation antigens or MHC class II antigens.
H, Merle-Béral +4 more
openaire +1 more source
Methyl Jasmonate: A New Treatment for B-CLL?.
Blood, 2006Abstract Jasmonates are a group of plant stress hormones, which play a role in activation of apoptosis and defense mechanisms. In vitro, it has been found that methyl jasmonate MJ induces death of lymphoma and leukemia cells by independent mechanisms involving mitochondrial damage at the level of the oxidative phosphorilation.
Eliezer Flescher +3 more
openaire +1 more source
B‐CLL WITH SURFACE IgMk PHENOTYPE
British Journal of Haematology, 1987A. Ferrant +9 more
openaire +2 more sources